Martin O Ota
Overview
Explore the profile of Martin O Ota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
566
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rusakaniko S, Makanga M, Ota M, Bockarie M, Banda G, Okeibunor J, et al.
Global Health
. 2019 Jul;
15(1):50.
PMID: 31349851
Background: Health challenges and health systems set-ups differ, warranting contextualised healthcare interventions to move towards universal health coverage. As such, there is emphasis on generation of contextualized evidence to solve...
2.
Nahimana M, Nyandwi A, Muhimpundu M, Olu O, Condo J, Rusanganwa A, et al.
BMC Public Health
. 2017 Jul;
18(1):2.
PMID: 28693458
Background: Hypertension is a leading cause of cardiovascular diseases and a growing public health problem in many developed and developing countries. However, population-based data to inform policy development are scarce...
3.
Tientcheu L, Bell A, Secka O, Ayorinde A, Otu J, Garton N, et al.
Int J Mycobacteriol
. 2017 Jan;
5 Suppl 1:S99-S100.
PMID: 28043641
Objectives/background: Mycobacterium africanum that causes 40% of tuberculosis (TB) in West Africa grows more slowly in culture and has similar transmission capacity compared with Mycobacterium tuberculosis, but M. africanum-exposed contacts...
4.
Idoko O, Hampton L, Mboizi R, Agbla S, Wallace A, Harris J, et al.
Vaccine
. 2016 Aug;
34(41):5034-5039.
PMID: 27570237
Background: As the World Health Organization (WHO) currently recommends that children be protected against 11 different pathogens, it is becoming increasingly necessary to administer multiple injectable vaccines during a single...
5.
Foster-Nyarko E, Kwambana B, Aderonke O, Ceesay F, Jarju S, Bojang A, et al.
BMC Microbiol
. 2016 May;
16:97.
PMID: 27230066
Background: In West Africa, the carriage of Group B Streptococcus (GBS), among infants is poorly characterised. We investigated co-carriage of GBS with other respiratory pathogens in the infants' nasopharynx in...
6.
Tientcheu L, Haks M, Agbla S, Sutherland J, Adetifa I, Donkor S, et al.
PLoS Negl Trop Dis
. 2016 May;
10(5):e0004701.
PMID: 27192147
Epidemiological differences exist between Mycobacterium africanum (Maf)- and Mycobacterium tuberculosis (Mtb)-infected patients, but to date, contributing host factors have not been characterised. We analysed clinical outcomes, as well as soluble...
7.
Sutherland J, Mendy J, Gindeh A, Walzl G, Togun T, Owolabi O, et al.
Tuberculosis (Edinb)
. 2016 Jan;
96:31-6.
PMID: 26786652
One of the key problems in combating TB is the lack of fast and accurate diagnostic tests that are affordable and easy to use in resource-limited settings. We have used...
8.
Odutola A, Afolabi M, Ogundare E, Lowe-Jallow Y, Worwui A, Okebe J, et al.
BMC Health Serv Res
. 2015 Aug;
15:346.
PMID: 26315547
Background: Vaccination has been shown to reduce mortality and morbidity due to vaccine-preventable diseases. However, these diseases are still responsible for majority of childhood deaths worldwide especially in the developing...
9.
Nanteza M, Kisakye A, Ota M, Gumede N, Bwogi J
J Med Virol
. 2015 Jun;
87(12):2163-7.
PMID: 26058454
A retrospective study to identify VAPP cases from the entire Uganda was conducted between January 2003 and December 2011. Eleven of the 106 AFP cases were VAPPs. The VAPP rate...
10.
Uthman O, Wiysonge C, Ota M, Nicol M, Hussey G, Ndumbe P, et al.
BMJ Open
. 2015 Mar;
5(3):e006340.
PMID: 25770227
Objective: To assess the profile and determinants of health research productivity in Africa since the onset of the new millennium. Design: Bibliometric analysis. Data Collection And Synthesis: In November 2014,...